The purpose of this panel discussion, which concluded the Tuesday BPI Theater sessions at BIO, was to introduce a new eBook, How to Jump Five Unforeseen Hurdles in Biotech Success, edited by Lisa LaMotta. Other contributors to the eBook — Ramani Varanasi (X-Biotix Therapeutics), Chris Haskell (Bayer Healthcare), Dan Geffken (Danforth Advisors), Luba Greenwood (Google’s Verily), Ailis Tweed-Kent (Cocoon Biotech), and Teresa Lavoie (Fish & Richardson) — joined LaMotta on this panel to explore ways of building an intellectual property (IP) portfolio, choosing a board of directors, and developing a partnering pitch.
Watch the full roundtable discussion below and leave your thoughts or questions on the topic below in the comments.
Life Sciences partnering events company EBD Group discusses the importance of communication, education, and the trials and tribulations of organizing an event with sustainability in mind.
Learn from the brightest minds in bioprocessing!
The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.